Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
State of the art of real-life concentration monitoring of rifampicin and its implementation contextualized in resource-limited settings: the Tanzanian case.
Petermann YJ, Said B, Cathignol AE, Sariko ML, Thoma Y, Mpagama SG, Csajka C, Guidi M. Petermann YJ, et al. Among authors: csajka c. JAC Antimicrob Resist. 2024 Nov 14;6(6):dlae182. doi: 10.1093/jacamr/dlae182. eCollection 2024 Dec. JAC Antimicrob Resist. 2024. PMID: 39544428 Free PMC article. Review.
Parametric Approaches in Population Pharmacokinetics.
Guidi M, Csajka C, Buclin T. Guidi M, et al. Among authors: csajka c. J Clin Pharmacol. 2022 Feb;62(2):125-141. doi: 10.1002/jcph.1633. Epub 2020 Oct 26. J Clin Pharmacol. 2022. PMID: 33103774 Review.
Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.
Burger R, Guidi M, Calpini V, Lamoth F, Decosterd L, Robatel C, Buclin T, Csajka C, Marchetti O. Burger R, et al. Among authors: csajka c. J Antimicrob Chemother. 2018 Dec 1;73(12):3413-3422. doi: 10.1093/jac/dky370. J Antimicrob Chemother. 2018. PMID: 30304491
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study.
Ravix A, Bandiera C, Cardoso E, Lata-Pedreira A, Chtioui H, Decosterd LA, Wagner AD, Schneider MP, Csajka C, Guidi M. Ravix A, et al. Among authors: csajka c. Cancers (Basel). 2024 Jun 11;16(12):2193. doi: 10.3390/cancers16122193. Cancers (Basel). 2024. PMID: 38927898 Free PMC article.
165 results